The Patent Finder

Terms ending in 2037

Ablynx N.V.

Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,553,901Methods for Detecting And/Or Measuring Anti-Drug Antibodies, in Particular Treatment-Emergent Anti-Drug Antibodies
In force
 · Medium confidence
Ablynx N.V.In forceMedium confidence
US 11,009,511Methods for Detecting And/Or Measuring Anti-Drug Antibodies, in Particular Treatment-Emergent Anti-Drug Antibodies
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 10,975,141Method for the Production of Immunoglobulin Single Variable Domains
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 11,851,480Method for the Production of Immunoglobulin Single Variable Domains
In force
 · Medium confidence
Ablynx N.V.In forceMedium confidence
US 11,919,966Methods for Inhibiting Tumor Growth or Treating Cancer by Administering an Immunoglobulin Single Variable Domain That Binds Glucocorticoid-Induced TNFR Family-Related Receptor (GITR)
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 11,753,465Nucleic Acids Encoding Polypeptides Against IL-23
In force
 · High confidence
SanofiIn forceHigh confidence
US 10,927,186T Cell Recruiting Polypeptides Based on TCR Alpha/Beta Reactivity
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 12,698,329T Cell Recruiting Polypeptides Capable of Binding CD123 and TCR Alpha/Beta
In force
 · Medium confidence
Ablynx N.V.In forceMedium confidence
US 12,662,527Improved Serum Albumin Binding Immunoglobulin Single Variable Domains
In force
 · High confidence
SanofiIn forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by Ablynx N.V..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited